Haemoglobin-H disease.
BINGLE JP, HUEHNS ER, PRANKERD TA.
Br Med J. 1958 Dec 6;2(5109):1389-90. doi: 10.1136/bmj.2.5109.1389.
The Clinical Phenotypes of Alpha Thalassemia.
Lal A, Vichinsky E.
Hematol Oncol Clin North Am. 2023 Apr;37(2):327-339. doi: 10.1016/j.hoc.2022.12.004.
Haemoglobin H disease and outcomes in Singapore.
Ang SH, Yee XJ, Pedro M, Tan GP, Tan WCR, Law HY, Chan MY.
Ann Acad Med Singap. 2022 Apr;51(4):244-246. doi: 10.47102/annals-acadmedsg.2021415.
Alpha and beta thalassemia.
Muncie HL Jr, Campbell J.
Am Fam Physician. 2009 Aug 15;80(4):339-44.
Clinical Classification, Screening and Diagnosis for Thalassemia.
Viprakasit V, Ekwattanakit S.
Hematol Oncol Clin North Am. 2018 Apr;32(2):193-211. doi: 10.1016/j.hoc.2017.11.006.
The α-thalassemias.
Piel FB, Weatherall DJ.
N Engl J Med. 2014 Nov 13;371(20):1908-16. doi: 10.1056/NEJMra1404415.
Acquired haemoglobin H disease.
Alli NA.
Hematology. 2005 Oct;10(5):413-8. doi: 10.1080/10245330500141689.
Liver complications of haemoglobin H disease in adults.
Chan LKL, Mak VWM, Chan SCH, Yu ELM, Chan NCN, Leung KFS, Ng CKM, Ng MHL, Chan JCW, Lee HKK.
Br J Haematol. 2021 Jan;192(1):171-178. doi: 10.1111/bjh.17115. Epub 2020 Oct 23.
Molecular basis of alpha-thalassemia.
Farashi S, Harteveld CL.
Blood Cells Mol Dis. 2018 May;70:43-53. doi: 10.1016/j.bcmd.2017.09.004. Epub 2017 Sep 21.
Epidemiology of clinically significant forms of alpha- and beta-thalassemia: A global map of evidence and gaps.
Musallam KM, Lombard L, Kistler KD, Arregui M, Gilroy KS, Chamberlain C, Zagadailov E, Ruiz K, Taher AT.
Am J Hematol. 2023 Sep;98(9):1436-1451. doi: 10.1002/ajh.27006. Epub 2023 Jun 26.
